ZIKV-IG

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameZIKV-IG
Drug Alias NameZika-virus-antibodies-Emergent-BiosolutionsZika-virus-immunotherapy-Emergent-BiosolutionsZika antibody therapeuticNP-024
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsZika Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesN/A
Active IndicationsZika Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A